Sentinus LLC’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.99M | Buy |
16,082
+101
| +0.6% | +$18.7K | 0.73% | 36 |
|
2025
Q1 | $3.35M | Buy |
15,981
+193
| +1% | +$40.4K | 0.94% | 30 |
|
2024
Q4 | $2.81M | Buy |
15,788
+239
| +2% | +$42.5K | 0.82% | 31 |
|
2024
Q3 | $3.07M | Buy |
15,549
+253
| +2% | +$50K | 0.92% | 26 |
|
2024
Q2 | $2.62M | Buy |
15,296
+1,223
| +9% | +$210K | 0.85% | 27 |
|
2024
Q1 | $2.56M | Buy |
+14,073
| New | +$2.56M | 0.9% | 26 |
|
2023
Q2 | $1.84M | Sell |
13,694
-138
| -1% | -$18.6K | 0.58% | 34 |
|
2023
Q1 | $2.2M | Buy |
13,832
+10,551
| +322% | +$1.68M | 0.74% | 28 |
|
2022
Q4 | $536K | Sell |
3,281
-9,565
| -74% | -$1.56M | 0.31% | 61 |
|
2022
Q3 | $1.72M | Buy |
+12,846
| New | +$1.72M | 1.08% | 23 |
|